Gvoke 1 mg per 0.2 mL single-dose vial and syringe Images
Generic Name: glucagon
This medication has been identified as Gvoke 1 mg per 0.2 mL single-dose vial and syringe. It is supplied by Xeris Pharmaceuticals, Inc.
Gvoke is used in the treatment of Hypoglycemia and belongs to the drug class glucose elevating agents. There is no proven risk in humans during pregnancy. Gvoke 1 mg per 0.2 mL single-dose vial and syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Gvoke
- Generic Name
- glucagon
- Strength
- 1 mg per 0.2 mL single-dose vial and syringe
- Availability
- Prescription only
- Drug Class
- Glucose elevating agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Xeris Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 72065-0140
More about Gvoke (glucagon)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: glucose elevating agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.